New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
10:41 EDTJD, OPEN, FIO, RH, NSR, ULTA, LULU, MONT, NWBO, OREXOptions with decreasing implied volatility
Options with decreasing implied volatility: OREX MONT ULTA NWBO LULU OPEN NSR FIO JD RH
News For OREX;MONT;ULTA;NWBO;LULU;OPEN;NSR;FIO;JD;RH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 27, 2015
16:15 EDTULTAULTA Beauty now sees FY15 EPS growth in high teens percentage
ULTA is raising its previously announced fiscal 2015 guidance to deliver earnings per share growth in the high teens, compared to previous guidance of the high end of the range of 15% to 17%. Consensus $4.81. The company is raising its previously announced fiscal 2015 guidance to achieve comparable sales growth of approximately 8%-10%, including the impact of the e-commerce business, compared to previous guidance of 7% to 9%. ULTA expects to increase total sales in the mid to high teens percentage range, consensus $3.85B.
16:12 EDTULTAULTA Beauty reports Q2 EPS $1.15, consensus $1.12
Subscribe for More Information
15:04 EDTULTAULTA Beauty September 160 straddle priced for 9.5% movement into Q2
14:58 EDTULTANotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Autodesk (ADSK), consensus 17c... ULTA Beauty (ULTA), consensus $1.12... Splunk (SPLK), consensus 2c... GameStop (GME), consensus 25c... Veeva (VEEV), consensus 11c... OmniVision (OVTI), consensus 39c... Aeropostale (ARO), consensus (55c).
12:16 EDTULTAULTA Beauty technical notes before earnings news
Shares are trading up ahead of earnings, last at $161. If the news is bullish, resistance areas to watch would be at $165.33, $171.21, and the life high at $176.77. If there is a bearish surprise, the shares given the extension in price recently would be vulnerable. Support levels to watch would be at $158.05, $153.26, and $149.13. There has been a strong line of support at the $150 area, going back to March of this year.
10:38 EDTRHWilliams-Sonoma sinks after earnings, BofA downgrade
Subscribe for More Information
07:56 EDTLULULululemon September weekly volatility elevated into Q2 and outlook
Lululemon 9/11/15 weekly call option implied volatility is at 66, September is at 61, October is at 48; compared to its 52-week range of 25 to 63, suggesting large near term price movement into the expected release of Q2 results on September 10.
07:52 EDTLULUBarclays would be a buyer of lululemon into the Q2 report
Barclays analyst Matt McClintock believes lululemon will report meaningful upside to his 7.7% total comp estimate when it reports Q2 earnings on September 10. Channel checks suggest a strong consumer response to new tops introduced in Q2 with stock outs above 50%, promising Google search activity, and momentum in men's. McClintock believes his earnings estimates will prove conservative and is a buyer into the report. Barclays' rates lululemon an Overweight with an $85 price target on shares.
August 26, 2015
08:07 EDTULTAULTA Beauty should report solid Q2 results, says Baird
Subscribe for More Information
August 25, 2015
11:22 EDTULTAULTA Beauty volatility elevated into Q2 and outlook
Subscribe for More Information
08:41 EDTULTAULTA Beauty to report above consensus Q2 results, says William Blair
William Blair analyst Daniel Hofkin predicts that ULTA Beauty will report Q2 earnings and comp-store sales above consensus estimates and said he views the current consensus forecast for Q3 comp sales and EPS as "reasonable." Hofkin maintains an Outperform rating on ULTA shares, stating that he views its valuation as defensible and he sees opportunities for the company to continue to gain "considerable" market share and exceed margin expectations.
August 21, 2015
15:26 EDTNWBONorthwest Biotherapeutics confirms Phase 3 trial of DCVax-L is ongoing
Northwest Biotherapeutics confirmed that its Phase III trial of DCVax-L for newly diagnosed glioblastoma multiforme is ongoing and the patients enrolled in the trial are continuing to be treated per the protocol. Over 300 patients have been recruited for the trial. The total anticipated enrollment is 348 patients. The only change in status of the trial is that new screening of patient candidates for the trial has been temporarily suspended while the company submits certain information from the trial for regulatory review. Such screening involves the initial evaluation of patient candidates to determine whether they meet eligibility criteria for the trial. Some blogs and social media comments have noted that the EudraCT trials database in Europe states that there is a "Temporary Halt" of the trial in Germany. In actuality, the trial status in Germany is that the trial is ongoing as noted above, and the company has only undertaken a temporary suspension of new screening. The company has sought to have the EudraCT listing corrected, but the database includes only certain pre-specified categories and there is no category that corresponds to a temporary suspension of new screening only, while a trial is ongoing. The company is in the process of preparing the trial information for regulatory review and anticipates submission within the next couple of weeks.
12:49 EDTNWBONorthwest Bio stops screening new patients in DCVax-L study, Reuters reports
Subscribe for More Information
09:13 EDTNWBOOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Accuray (ARAY), up 12.7%... Brocade (BRCD), up 6%... salesforce.com (CRM), up 3.5%. DOWN AFTER EARNINGS: Intuit (INTU), down 6.7%... Deere (DE), down 5.4%... Nordson (NDSN), down 4.4%. ALSO LOWER: GigOptix (GIG), down 20% after 9.22M share Spot Secondary priced at $1.70... VirnetX Holding (VHC), down 19.8% after filing to sell 35M shares of common stock... Northwest Biotherapeutics (NWBO), down 8.7% after TheStreet's Adam Feuerstein reports, via Twitter, that CVax Phase 3 study has been temporarily halted in Germany.
08:49 EDTNWBONorthwest Phase 3 study halted in Germany TheStreet's Feuerstein says
The European Union Clinical Trials Register says Northwest Biotherapeutics' DCVax Phase 3 study has been "temporarily halted" in Germany, TheStreet's Adam Feuerstein reports via Twitter. Shares of Northwest are down 63c to $8.25 in pre-market trading.
August 20, 2015
07:20 EDTJDCitigroup to hold a conference
Hong Kong / China Corporate Day is being held in Hong Kong on August 20.
August 18, 2015
10:19 EDTULTAOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTLULUOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abercrombie & Fitch (ANF) initiated with an Underperform at Wolfe Research... Abiomed (ABMD) initiated with a Buy at CRT Capital... Aeropostale (ARO) initiated with a Peer Perform at Wolfe Research... American Eagle (AEO) initiated with an Outperform, Top Pick at Wolfe Research... American Electric (AEP) initiated with a Buy at Mizuho... Benefitfocus (BNFT) initiated with an Overweight at First Analysis... Blue Buffalo Pet Products (BUFF) initiated with an Equal Weight at Morgan Stanley... Capitala Finance (CPTA) initiated with an Equal Weight at Stephens... Chico's (CHS) initiated with a Peer Perform at Wolfe Research... Children's Place (PLCE) initiated with an Outperform at Wolfe Research... Chimerix (CMRX) initiated with an Outperform at FBR Capital... Ciena (CIEN) initiated with a Market Perform at Northland... Crane (CR) initiated with an Outperform at William Blair... Entergy (ETR) initiated with a Neutral at Mizuho... Express (EXPR) initiated with an Outperform, Top Pick at Wolfe Research... Finisar (FNSR) initiated with a Market Perform at Northland... Francesca's (FRAN) initiated with a Peer Perform at Wolfe Research... Gap (GPS) initiated with an Underperform at Wolfe Research... Infinera (INFN) initiated with an Outperform at Northland... International Game (IGT) initiated with a Buy at Union Gaming... Juno Therapeutics (JUNO) initiated with an Outperform at FBR Capital... L Brands (LB) initiated with a Peer Perform at Wolfe Research... Luca Technologies (LUCA) initiated with an Outperform at Northland... Lumentum (LITE) initiated with an Outperform at Northland... M/A-COM (MTSI) reinstated with a Buy at Jefferies... MRV Communications (MRVC) initiated with an Outperform at Northland... Michael Kors (KORS) initiated with a Peer Perform at Wolfe Research... NN, Inc. (NNBR) initiated with a Buy at Stifel... NeoPhotonics (NPTN) initiated with an Outperform at Northland... Oclaro (OCLR) initiated with an Outperform at Northland... Scientific Games (SGMS) initiated with a Buy at Sterne Agee CRT... SolarCity (SCTY) initiated with a Neutral at UBS... Summit Materials (SUM) initiated with a Neutral at Citi... Tech Data (TECD) initiated with an Underperform at BofA/Merrill... Urban Outfitters (URBN) initiated with a Peer Perform at Wolfe Research... Zumiez (ZUMZ) initiated with an Underperform at Wolfe Research... lululemon (LULU) initiated with a Peer Perform at Wolfe Research.
05:30 EDTJDTuniu launches product portfolio on JD.com leasure travel channel
Subscribe for More Information
August 17, 2015
16:57 EDTLULUlululemon initiated with a Peer Perform at Wolfe Research
Target $65.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use